Unknown

Dataset Information

0

Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children.


ABSTRACT: Invasive aspergillosis (IA) is associated with significant morbidity and mortality. Voriconazole remains the drug of choice for the treatment of IA in children; however, the complex kinetics of voriconazole in children make dosing challenging and therapeutic drug monitoring (TDM) essential for treatment success. The overarching goal of this review is to discuss the role of voriconazole, posaconazole, isavuconazole, liposomal amphotericin B, echinocandins, and combination antifungal therapy for the treatment of IA in children. We also provide a detailed discussion of antifungal TDM in children.

SUBMITTER: Hsu AJ 

PROVIDER: S-EPMC9295552 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children.

Hsu Alice J AJ   Tamma Pranita D PD   Fisher Brian T BT  

Antimicrobial agents and chemotherapy 20220629 7


Invasive aspergillosis (IA) is associated with significant morbidity and mortality. Voriconazole remains the drug of choice for the treatment of IA in children; however, the complex kinetics of voriconazole in children make dosing challenging and therapeutic drug monitoring (TDM) essential for treatment success. The overarching goal of this review is to discuss the role of voriconazole, posaconazole, isavuconazole, liposomal amphotericin B, echinocandins, and combination antifungal therapy for t  ...[more]

Similar Datasets

| S-EPMC10503299 | biostudies-literature
| S-EPMC7559350 | biostudies-literature
| S-EPMC7376672 | biostudies-literature
| S-EPMC6463058 | biostudies-literature
| S-EPMC5753081 | biostudies-other
2013-03-11 | E-ERAD-70 | biostudies-arrayexpress
| S-EPMC9962768 | biostudies-literature
| S-EPMC10132806 | biostudies-literature
| S-EPMC6490690 | biostudies-literature
| S-EPMC8730679 | biostudies-literature